The HTA Review Reference Committee will oversee the Health Technology Assessment (HTA) Policy and Methods Review’
The HTA Review Reference Committee will:
- agree the terms of reference for the HTA Review
- agree the expert in HTA to support the HTA Review
- oversee public consultations and considering submissions to the HTA Review
- oversee the analysis undertaken by the expert in HTA
- prepare a final review report and recommendations.
|Member||Role on the Reference Committee|
|Adjunct Professor Debora Picone AO||Independent Chair|
|Ms Ann Single||Patient Representative|
|Dr Dawn Casey PSM||Patient Representative|
|Professor Andrew Wilson||Chair of the Pharmaceutical Benefits Advisory Committee (PBAC)|
|Professor Andrew Roberts AM||Clinical/Scientific Representative|
|Ms Elizabeth de Somer||Member nominated by Medicines Australia|
|Ms Adriana Platona PSM||Government Nominee|
The committee holds meetings as needed to meet the 31 December 2023 review deadline.
The committee will publish upcoming meeting agendas.
Health Technology Assessment Policy and Methods Review reference committee – Meeting agendas
This collection contains meeting agendas from the Health Technology Assessment Policy and Methods Review reference committee.
Health Technology Assessment Policy and Methods Review reference committee – Communiques
This collection contains communiques from the Health Technology Assessment Policy and Methods Review reference committee.
Health Technology Assessment Review – Probity Plan
The Probity Plan outlines the probity principles and processes agreed by the Reference Committee for the HTA Review.
HTA Review Secretariat
Contact for the Health Technology Assessment Review